» Articles » PMID: 17043886

Procalcitonin Serum Levels in Children Undergoing Chronic Haemodialysis

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2006 Oct 18
PMID 17043886
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Infections account for considerable morbidity and mortality in patients requiring haemodialysis (HD). Procalcitonin (PCT)-a low molecular weight protein of 13 kDa-helps one to distinguish viral from bacterial infections and to evaluate the severity of bacterial infections. We investigated (1) PCT baseline levels in eight children undergoing chronic HD with high-flux membranes and (2) changes in the serum levels of PCT, C-reactive protein (CRP) and beta-2-microglobulin (beta2-MG)-a peptide with biochemical characteristics similar to those of PCT-before and after haemodialysis sessions. Blood sampling was performed three times in the mid-week session. Serum PCT of the seven uninfected children before HD sessions was increased (0.75+/-0.07 ng/ml), whereas CRP levels were normal. PCT after dialysis decreased significantly by 40% (P<0.0001) compared with initial values, whereas CRP levels before and after HD were not different. beta2-MG decreased by 70%, probably due to different biochemical properties of both proteins. PCT serum levels 15 min and 60 min after the HD session remained unchanged in comparison with those at the end of the HD session, suggesting accumulation of PCT between HD sessions rather than HD-induced production to be responsible for the increased baseline PCT serum levels. We concluded that CRP serum levels were not affected by HD in our group. Moderately elevated baseline PCT serum levels that are presumably due to reduced renal clearance and uraemia and dialysis-ability of PCT should be taken into consideration. However, increase of serum PCT in patients with severe bacterial infections is generally massive (10-fold to 1,000-fold), suggesting a low risk for false negative results in such cases.

Citing Articles

Diagnostic and Prognostic Roles of Procalcitonin and Other Tools in Community-Acquired Pneumonia: A Narrative Review.

Ozbay S, Ayan M, Ozsoy O, Akman C, Karcioglu O Diagnostics (Basel). 2023; 13(11).

PMID: 37296721 PMC: 10253144. DOI: 10.3390/diagnostics13111869.


Diagnostic value of procalcitonin for bacterial infections in patients undergoing hemodialysis: a systematic review and meta-analysis.

Tao M, Zheng D, Liang X, He Q, Zhang W Ren Fail. 2022; 44(1):81-93.

PMID: 35164633 PMC: 8856046. DOI: 10.1080/0886022X.2021.2021236.


Procalcitonin serum levels in stage 5 chronic kidney disease children on hemodialysis.

Mouche A, Parmentier C, Herbez Rea C, Kwon T, Boyer O, Delbet J Pediatr Nephrol. 2021; 36(8):2405-2409.

PMID: 33730285 DOI: 10.1007/s00467-021-04966-4.


Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage.

Sun Y, Jiang L, Shao X Int Urol Nephrol. 2017; 49(12):2205-2216.

PMID: 28956241 DOI: 10.1007/s11255-017-1710-z.


Usefulness of serum procalcitonin as a diagnostic biomarker of infection in children with chronic kidney disease.

Fadel F, Elshamaa M, Elghoroury E, Badr A, Kamel S, El-Sonbaty M Arch Med Sci Atheroscler Dis. 2017; 1(1):e23-e31.

PMID: 28905015 PMC: 5421526. DOI: 10.5114/amsad.2016.59672.


References
1.
Owen W, Lowrie E . C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998; 54(2):627-36. DOI: 10.1046/j.1523-1755.1998.00032.x. View

2.
Balci C, Sungurtekin H, Gurses E, Sungurtekin U, Kaptanoglu B . Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care. 2003; 7(1):85-90. PMC: 154110. DOI: 10.1186/cc1843. View

3.
Nylen E, Whang K, Snider Jr R, Steinwald P, White J, Becker K . Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998; 26(6):1001-6. DOI: 10.1097/00003246-199806000-00015. View

4.
Balog A, Ocsovszki I, Mandi Y . Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes. Immunol Lett. 2002; 84(3):199-203. DOI: 10.1016/s0165-2478(02)00158-x. View

5.
Conti G, Amore A, Chiesa M, Mancuso D, Cirina P, Mengozzi G . Procalcitonin as a marker of micro-inflammation in hemodialysis. J Nephrol. 2005; 18(3):282-8. View